| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Aggarwal S et al. | QSAR studies on human 5alpha-reductase inhibitors: unsaturated 3-carboxysteroids. | 2011 May-Jun | Acta Pol Pharm | pmid:21648201 |
| MotlÃk K and Stárka L | 4-Cholesten-3-one-induced lipoid hyperplasia of the adrenal cortex in rats. | 1983 | Acta Univ Carol Med (Praha) | pmid:6637679 |
| Juan Escudero JU et al. | [Green light laser efficacy in patients with prostatic hyperplasia treatment with 5-alpha reductase inhibitors]. | 2009 | Actas Urol Esp | pmid:19925759 |
| Campbell SM et al. | Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. | 2002 | AIDS | pmid:12441796 |
| Ford MM et al. | Inhibition of 5alpha-reduced steroid biosynthesis impedes acquisition of ethanol drinking in male C57BL/6J mice. | 2008 | Alcohol. Clin. Exp. Res. | pmid:18565155 |
| Gorin RE et al. | Effects of finasteride on chronic and acute ethanol withdrawal severity in the WSP and WSR selected lines. | 2005 | Alcohol. Clin. Exp. Res. | pmid:15976519 |
| Walters JR et al. | The response of patients with bile acid diarrhoea to the farnesoid X receptor agonist obeticholic acid. | 2015 | Aliment. Pharmacol. Ther. | pmid:25329562 |
| Liu KZ et al. | Oxidative status of lipoproteins in coronary disease patients. | 1992 | Am. Heart J. | pmid:1736561 |
| Shimoda H et al. | The hypocholesterolemic effects of Cistanche tubulosa extract, a Chinese traditional crude medicine, in mice. | 2009 | Am. J. Chin. Med. | pmid:19938221 |
| Yoshida T et al. | Origin of oxysterols in hepatic bile of patients with biliary infection. | 2003 | Am. J. Gastroenterol. | pmid:14572579 |
| Borst SE et al. | Inhibition of 5alpha-reductase blocks prostate effects of testosterone without blocking anabolic effects. | 2005 | Am. J. Physiol. Endocrinol. Metab. | pmid:15367394 |
| Sato K et al. | Increased muscular dehydroepiandrosterone levels are associated with improved hyperglycemia in obese rats. | 2011 | Am. J. Physiol. Endocrinol. Metab. | pmid:21285401 |
| Borst SE et al. | Anabolic effects of testosterone are preserved during inhibition of 5alpha-reductase. | 2007 | Am. J. Physiol. Endocrinol. Metab. | pmid:17488806 |
| Seo DW et al. | Oxysterols from human bile induce apoptosis of canine gallbladder epithelial cells in monolayer culture. | 2004 | Am. J. Physiol. Gastrointest. Liver Physiol. | pmid:15246959 |
| Abe M et al. | Isolation and pharmacological characterization of fatty acids from saw palmetto extract. | 2009 | Anal Sci | pmid:19359798 |
| Sugano S et al. | Sensitive assay of cytochrome P450scc activity by high-performance liquid chromatography. | 1989 | Anal. Biochem. | pmid:2610350 |
| Brun EM et al. | Enzyme-linked immunosorbent assays for doping control of 5alpha-reductase inhibitors finasteride and dutasteride. | 2010 | Anal. Chim. Acta | pmid:20541645 |
| Gooren LJ et al. | Decline of plasma 5alpha-dihydrotestosterone (DHT) levels upon testosterone administration to elderly men with subnormal plasma testosterone and high DHT levels. | 2008 | Andrologia | pmid:18811920 |
| Kolasa A et al. | Expression of E-SOD, GPX5 mRNAs and immunoexpression of Cu/ZnSOD in epididymal epithelial cells of finasteride-treated rats. | 2008 | Andrologia | pmid:18811921 |
| Yassin AA and Saad F | Plasma levels of dihydrotestosterone remain in the normal range in men treated with long-acting parenteral testosterone undecanoate. | 2007 | Andrologia | pmid:17714216 |
| Dolder CR | Dutasteride: a dual 5-alpha reductase inhibitor for the treatment of symptomatic benign prostatic hyperplasia. | 2006 | Ann Pharmacother | pmid:16569804 |
| Al-Mutair A et al. | Cytogenetics and etiology of ambiguous genitalia in 120 pediatric patients. | 2004 Sep-Oct | Ann Saudi Med | pmid:15573851 |
| Trinder P | Oxidase determination of plasma cholesterol as cholest-4-en-3-one using iso-octane extraction. | 1981 | Ann. Clin. Biochem. | pmid:6942786 |
| Vallarino M et al. | Ontogeny of 3 beta-hydroxysteroid dehydrogenase and 5 alpha-reductase in the frog brain. | 2005 | Ann. N. Y. Acad. Sci. | pmid:15891098 |
| Magalon K et al. | Olesoxime accelerates myelination and promotes repair in models of demyelination. | 2012 | Ann. Neurol. | pmid:22367994 |
| Sampson NS | Dissection of a flavoenzyme active site: the reaction catalyzed by cholesterol oxidase. | 2001 | Antioxid. Redox Signal. | pmid:11761331 |
| Chiang YR et al. | Cholest-4-en-3-one-delta 1-dehydrogenase, a flavoprotein catalyzing the second step in anoxic cholesterol metabolism. | 2008 | Appl. Environ. Microbiol. | pmid:17993555 |
| Mieczkowska J et al. | Changes in the activity of connective tissue matrix enzymes in the metabolic syndrome. | 2011 | Arch Med Sci | pmid:22291799 |
| Yin Y et al. | Construction of a catalytically inactive cholesterol oxidase mutant: investigation of the interplay between active site-residues glutamate 361 and histidine 447. | 2002 | Arch. Biochem. Biophys. | pmid:12051668 |
| Chung DE and Kaplan SA | Current role for combination therapy in male LUTS. | 2010 | Arch. Esp. Urol. | pmid:20587837 |
| Tibolla G et al. | Increased atherosclerosis and vascular inflammation in APP transgenic mice with apolipoprotein E deficiency. | 2010 | Atherosclerosis | pmid:19945109 |
| Martel C et al. | Inhibition of the Mitochondrial Permeability Transition for Cytoprotection: Direct versus Indirect Mechanisms. | 2012 | Biochem Res Int | pmid:22675634 |
| Yoshimoto T et al. | Polyethylene glycol derivative-modified cholesterol oxidase soluble and active in benzene. | 1987 | Biochem. Biophys. Res. Commun. | pmid:3479986 |
| Pucadyil TJ et al. | Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin(1A) receptors. | 2005 | Biochem. Biophys. Res. Commun. | pmid:15850776 |
| Murphy PR et al. | Binding of oxygenated cholesterol metabolites to antiestrogen binding sites from chicken liver. | 1985 | Biochem. Biophys. Res. Commun. | pmid:3985957 |
| Liu S and Yamauchi H | Different patterns of 5alpha-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells. | 2008 | Biochem. Biophys. Res. Commun. | pmid:18258185 |
| Lim L et al. | Structural and kinetic analyses of the H121A mutant of cholesterol oxidase. | 2006 | Biochem. J. | pmid:16856877 |
| Rovini A et al. | Olesoxime prevents microtubule-targeting drug neurotoxicity: selective preservation of EB comets in differentiated neuronal cells. | 2010 | Biochem. Pharmacol. | pmid:20417191 |
| Smith AG and Brooks CJ | The mechanism of the isomerization of Cholest-5-en-3-one to cholest-4-en-3-one by cholesterol oxidase [proceedings]. | 1977 | Biochem. Soc. Trans. | pmid:913789 |
| Yin Y et al. | The presence of a hydrogen bond between asparagine 485 and the pi system of FAD modulates the redox potential in the reaction catalyzed by cholesterol oxidase. | 2001 | Biochemistry | pmid:11705367 |
| Ahn KW and Sampson NS | Cholesterol oxidase senses subtle changes in lipid bilayer structure. | 2004 | Biochemistry | pmid:14730988 |
| Faucher F et al. | The crystal structure of human Delta4-3-ketosteroid 5beta-reductase defines the functional role of the residues of the catalytic tetrad in the steroid double bond reduction mechanism. | 2008 | Biochemistry | pmid:18624455 |
| Pang L et al. | Membrane cholesterol modulates galanin-GalR2 interaction. | 1999 | Biochemistry | pmid:10508403 |
| Charbonneau A and The VL | Genomic organization of a human 5beta-reductase and its pseudogene and substrate selectivity of the expressed enzyme. | 2001 | Biochim. Biophys. Acta | pmid:11342103 |
| Buchmann MS et al. | Metabolism of the cholestanol precursor cholesta-4,6-dien-3-one in different tissues. | 1987 | Biochim. Biophys. Acta | pmid:3676336 |
| Rebolj K et al. | Steroid structural requirements for interaction of ostreolysin, a lipid-raft binding cytolysin, with lipid monolayers and bilayers. | 2006 | Biochim. Biophys. Acta | pmid:16857161 |
| Slotte JP and Ostman AL | Oxidation/isomerization of 5-cholesten-3 beta-ol and 5-cholesten-3-one to 4-cholesten-3-one in pure sterol and mixed phospholipid-containing monolayers by cholesterol oxidase. | 1993 | Biochim. Biophys. Acta | pmid:8431456 |
| Stokes NA and Hylemon PB | Characterization of delta 4-3-ketosteroid-5 beta-reductase and 3 beta-hydroxysteroid dehydrogenase in cell extracts of Clostridium innocuum. | 1985 | Biochim. Biophys. Acta | pmid:3861198 |
| Monte MJ et al. | Transient changes in the expression pattern of key enzymes for bile acid synthesis during rat liver regeneration. | 2005 | Biochim. Biophys. Acta | pmid:15904869 |
| Slotte JP | Direct observation of the action of cholesterol oxidase in monolayers. | 1995 | Biochim. Biophys. Acta | pmid:7488639 |
| Liu J et al. | 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum. | 2006 | Biol. Pharm. Bull. | pmid:16462054 |
| Lin AS et al. | Structure and biological evaluation of novel cytotoxic sterol glycosides from the marine red alga Peyssonnelia sp. | 2010 | Bioorg. Med. Chem. | pmid:21036050 |
| Suzuki K et al. | The cholesterol metabolite cholest-4-en-3-one and its 3-oxo derivatives suppress body weight gain, body fat accumulation and serum lipid concentration in mice. | 1998 | Bioorg. Med. Chem. Lett. | pmid:9873500 |
| Beattie ME et al. | Sterol structure determines miscibility versus melting transitions in lipid vesicles. | 2005 | Biophys. J. | pmid:15951379 |
| Stottrup BL and Keller SL | Phase behavior of lipid monolayers containing DPPC and cholesterol analogs. | 2006 | Biophys. J. | pmid:16461392 |
| Ghosh S et al. | Cholesterol-oxidase-magnetic nanobioconjugates for the production of 4-cholesten-3-one and 4-cholesten-3, 7-dione. | 2018 | Bioresour. Technol. | pmid:29413944 |
| Fujii T et al. | Efficient biotransformations using Escherichia coli with tolC acrAB mutations expressing cytochrome P450 genes. | 2009 | Biosci. Biotechnol. Biochem. | pmid:19352031 |
| Malik V and Pundir CS | Determination of total cholesterol in serum by cholesterol esterase and cholesterol oxidase immobilized and co-immobilized on to arylamine glass. | 2002 | Biotechnol. Appl. Biochem. | pmid:12074697 |
| Liu XC and Kayser L | New approach to regioselective synthesis: using proteins in vitro as guidance-regioselective reduction of steroids with guidance from bovine serum albumin. | 2003 | Biotechnol. Bioeng. | pmid:12701153 |
| Carneiro MM et al. | Androgen receptor and 5alpha-reductase are expressed in pelvic endometriosis. | 2008 | BJOG | pmid:17983420 |
| Fitzpatrick JM et al. | Prostate cancer: a serious disease suitable for prevention. | 2009 | BJU Int. | pmid:19302133 |
| Schröder FH et al. | Can dutasteride delay or prevent the progression of prostate cancer in patients with biochemical failure after radical therapy? Rationale and design of the Avodart after Radical Therapy for Prostate Cancer Study. | 2009 | BJU Int. | pmid:19226424 |
| Evans CP et al. | An evidence-based approach to understanding the pharmacological class effect in the management of prostatic diseases. | 2005 | BJU Int. | pmid:15794775 |
| Chapple CR | Pharmacological therapy of benign prostatic hyperplasia/lower urinary tract symptoms: an overview for the practising clinician. | 2004 | BJU Int. | pmid:15329091 |
| Djavan B et al. | Testosterone in prostate cancer: the Bethesda consensus. | 2012 | BJU Int. | pmid:22129242 |
| Hong SK et al. | Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia. | 2010 | BJU Int. | pmid:19793378 |
| Nguyen DH and Taub D | Cholesterol is essential for macrophage inflammatory protein 1 beta binding and conformational integrity of CC chemokine receptor 5. | 2002 | Blood | pmid:12036855 |
| Volontè F et al. | Production of recombinant cholesterol oxidase containing covalently bound FAD in Escherichia coli. | 2010 | BMC Biotechnol. | pmid:20409334 |
| Sojo MM et al. | Rhodococcus erythropolis ATCC 25544 as a suitable source of cholesterol oxidase: cell-linked and extracellular enzyme synthesis, purification and concentration. | 2002 | BMC Biotechnol. | pmid:11914155 |
| Wiebe JP and Lewis MJ | Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cells. | 2003 | BMC Cancer | pmid:12659654 |
| Wilt TJ and N'Dow J | Benign prostatic hyperplasia. Part 2--management. | 2008 | BMJ | pmid:18219042 |
| Kasashima S et al. | Androgen receptor and 5alpha-reductase immunohistochemical profiles in extramammary Paget disease. | 2010 | Br. J. Dermatol. | pmid:19995364 |
| Frye CA et al. | Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase. | 2004 | Brain Res. | pmid:15033426 |
| Stuart EB et al. | Steroid hormone influence on brain calbindin-D(28K) in male prepubertal and ovariectomized rats. | 2001 | Brain Res. Dev. Brain Res. | pmid:11506857 |
| Ribeiro ML et al. | Allelic frequencies of six polymorphic markers for risk of prostate cancer. | 2002 | Braz. J. Med. Biol. Res. | pmid:11847524 |
| Yang C et al. | A49T, V89L and TA repeat polymorphisms of steroid 5alpha-reductase type II and breast cancer risk in Japanese women. | 2002 | Breast Cancer Res. | pmid:12100746 |
| Bairamov AA and Sapronov NS | Effect of dehydroepiandrosterone on radioligand binding of [3H]-testosterone by androgen receptors in rat hypothalamus. | 2004 | Bull. Exp. Biol. Med. | pmid:15665952 |
| Maria McCrohan A et al. | Effects of the dual 5 alpha-reductase inhibitor dutasteride on apoptosis in primary cultures of prostate cancer epithelial cells and cell lines. | 2006 | Cancer | pmid:16703599 |
| Wu AH et al. | Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men. | 2001 | Cancer Epidemiol. Biomarkers Prev. | pmid:11352865 |
| Ntais C et al. | SRD5A2 gene polymorphisms and the risk of prostate cancer: a meta-analysis. | 2003 | Cancer Epidemiol. Biomarkers Prev. | pmid:12869400 |
| Hsing AW et al. | Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study. | 2001 | Cancer Epidemiol. Biomarkers Prev. | pmid:11588134 |
| Suzuki K et al. | Characterization of cytotoxic steroids in human faeces and their putative role in the etiology of human colonic cancer. | 1986 | Cancer Lett. | pmid:3802059 |
| Lee HH et al. | Theaflavin-3,3'-digallate and penta-O-galloyl-beta-D-glucose inhibit rat liver microsomal 5alpha-reductase activity and the expression of androgen receptor in LNCaP prostate cancer cells. | 2004 | Carcinogenesis | pmid:14963012 |
| Motola DL et al. | Identification of ligands for DAF-12 that govern dauer formation and reproduction in C. elegans. | 2006 | Cell | pmid:16529801 |
| Ma J et al. | 4-cholesten-3-one suppresses lung adenocarcinoma metastasis by regulating translocation of HMGB1, HIF1α and Caveolin-1. | 2016 | Cell Death Dis | pmid:27899819 |
| Guardiola-Serrano F et al. | Palmitoylation of human FasL modulates its cell death-inducing function. | 2010 | Cell Death Dis | pmid:21368861 |
| Rouquette-Jazdanian AK et al. | Revaluation of the role of cholesterol in stabilizing rafts implicated in T cell receptor signaling. | 2006 | Cell. Signal. | pmid:15925486 |
| Liu J et al. | Anti-androgenic activity of fatty acids. | 2009 | Chem. Biodivers. | pmid:19353546 |
| Chen M et al. | The rate-determining steps of aldo-keto reductases (AKRs), a study on human steroid 5β-reductase (AKR1D1). | 2015 | Chem. Biol. Interact. | pmid:25500266 |
| Lintker KB et al. | A comparison of the packing behavior of egg phosphatidylcholine with cholesterol and biogenically related sterols in Langmuir monolayer films. | 2009 | Chem. Phys. Lipids | pmid:19524563 |
| Benesch MG et al. | A DSC and FTIR spectroscopic study of the effects of the epimeric 4-cholesten-3-ols and 4-cholesten-3-one on the thermotropic phase behaviour and organization of dipalmitoylphosphatidylcholine bilayer membranes: comparison with their 5-cholesten analogues. | 2014 | Chem. Phys. Lipids | pmid:24296232 |
| Miller J and Tarter TH | Combination therapy with dutasteride and tamsulosin for the treatment of symptomatic enlarged prostate. | 2009 | Clin Interv Aging | pmid:19554096 |
| Wheeler RE | Is it necessary to cure prostate cancer when it is possible? (Understanding the role of prostate inflammation resolution to prostate cancer evolution). | 2007 | Clin Interv Aging | pmid:18044088 |
| van Gorselen EO et al. | Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia. | 2010 | Clin Res Cardiol | pmid:20593189 |
| Kotłowska A et al. | The urinary steroid profile in patients diagnosed with adrenal incidentaloma. | 2009 | Clin. Biochem. | pmid:19297679 |
| Donato LJ et al. | Description of analytical method and clinical utility of measuring serum 7-alpha-hydroxy-4-cholesten-3-one (7aC4) by mass spectrometry. | 2018 | Clin. Biochem. | pmid:29051033 |
| Taplin ME et al. | Phase II study of androgen synthesis inhibition with ketoconazole, hydrocortisone, and dutasteride in asymptomatic castration-resistant prostate cancer. | 2009 | Clin. Cancer Res. | pmid:19887483 |
| Mohler JL et al. | Potential prostate cancer drug target: bioactivation of androstanediol by conversion to dihydrotestosterone. | 2011 | Clin. Cancer Res. | pmid:21705451 |
| Dixon J et al. | Prolonged human chorionic gonadotrophin stimulation as a tool for investigating and managing undescended testes. | 2007 | Clin. Endocrinol. (Oxf) | pmid:17645564 |
4-Cholesten-3-one
4-Cholesten-3-one is a lipid of Sterol Lipids (ST) class. 4-cholesten-3-one is associated with abnormalities such as Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana and Xanthoma. The involved functions are known as CYP27A1activity, 25-hydroxycholesterol 7alpha-hydroxylase activity, Biochemical Pathway, Anabolism and Oxidation. 4-cholesten-3-one often locates in Mitochondria, Liver, Body tissue, Hepatic, Mitochondria and Endothelium of artery. The associated genes with 4-Cholesten-3-one are P4HTM gene, tryptones and Regulon. The related lipids are Cholestenones, 7-hydroxy-4-cholesten-3-one, cholest-4-en-3-one, 25-hydroxycholesterol and 24-hydroxycholesterol.
Cross Reference
Introduction
To understand associated biological information of 4-Cholesten-3-one, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with 4-Cholesten-3-one?
4-Cholesten-3-one is suspected in Dehydration, Xanthomatosis, Cerebrotendinous, Peripheral Neuropathy, L.mexicana, Xanthoma, Rare Diseases and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Biochem. J. (1)
- J. Biol. Chem. (1)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- Others (3)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
No disease MeSH terms mapped to the current reference collection.
PubChem Associated disorders and diseases
What pathways are associated with 4-Cholesten-3-one
Lipid pathways are not clear in current pathway databases. We organized associated pathways with 4-Cholesten-3-one through full-text articles, including metabolic pathways or pathways of biological mechanisms.
Related references are published most in these journals:
| Pathway name | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with 4-Cholesten-3-one?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
- J. Biol. Chem. (2)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- J. Lipid Res. (1)
- Others (2)
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
- J. Biol. Chem. (2)
- J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. (1)
- J. Lipid Res. (1)
- Others (3)
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with 4-Cholesten-3-one?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with 4-Cholesten-3-one?
There are no associated biomedical information in the current reference collection.